5-Aminolevulinic Acid False-Positive Rates in Newly Diagnosed and Recurrent Glioblastoma: Do Pseudoprogression and Radionecrosis Play a Role? A Meta-Analysis

5-Aminolevulinic Acid False-Positive Rates in Newly Diagnosed and Recurrent Glioblastoma: Do Pseudoprogression and Radionecrosis Play a Role? A Meta-Analysis

BackgroundSeveral studies have confirmed the impact of 5-aminolevulinic acid (5-ALA) on the extent of resection in newly diagnosed glioblastoma (GBM). However, there are controversies on the 5-ALA fluorescence status in recurrent GBM surgery, with specific reference to pseudoprogression or radionecr...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron:	Luca Ricciardi, Carmelo Lucio Sturiale, Alba Scerrati, Vito Stifano, Teresa Somma, Tamara Ius, Sokol Trungu, Michele Acqui, Antonino Raco, Massimo Miscusi, Giuseppe Maria Della Pepa
Fformat:	Erthygl
Iaith:	English
Cyhoeddwyd:	Frontiers Media S.A. 2022-02-01
Cyfres:	Frontiers in Oncology
Pynciau:	glioblastoma high-grade glioma (HGG) recurrent glioblastoma 5-ALA fluorescence pseudoprogression radionecrosis
Mynediad Ar-lein:	https://www.frontiersin.org/articles/10.3389/fonc.2022.848036/full

Eitemau Tebyg

The influence of endothelial hyperplasia on pseudoprogression development in patients with glioblastoma
gan: Petrović Marko, et al.
Cyhoeddwyd: (2019-01-01)

The Potential Use of Radiomics with Pre-Radiation Therapy MR Imaging in Predicting Risk of Pseudoprogression in Glioblastoma Patients
gan: Michael Baine, et al.
Cyhoeddwyd: (2021-01-01)

The predictive value of absolute lymphocyte counts on tumor progression and pseudoprogression in patients with glioblastoma
gan: Jing Xi, et al.
Cyhoeddwyd: (2021-03-01)

The complementary role of MRI and FET PET in high-grade gliomas to differentiate recurrence from radionecrosis
gan: Arpita Sahu, et al.
Cyhoeddwyd: (2023-04-01)

Study Protocol of a Prospective Phase 2 Study of Chlorophyllin for the Management of Brain Radionecrosis in Patients With Diffuse Glioma (CHROME)
gan: Archya Dasgupta, et al.
Cyhoeddwyd: (2025-03-01)

Pseudoprogression in Glioblastoma: Role of Metabolic and Functional MRI-Systematic Review
gan: Ingrid Sidibe, et al.
Cyhoeddwyd: (2022-01-01)

In silico study of pseudoprogression in glioblastoma: collaboration of radiologists and radiation oncologists in the estimation of extent of high dose RT region
gan: Renata Belanova, et al.
Cyhoeddwyd: (2020-09-01)

Differentiating tumour progression from pseudoprogression in glioblastoma patients: a monoexponential, biexponential, and stretched-exponential model-based DWI study
gan: Dan Liao, et al.
Cyhoeddwyd: (2023-09-01)

Myeloid cells as potential targets for immunotherapy in pediatric gliomas
gan: Stephen C. Frederico, et al.
Cyhoeddwyd: (2024-03-01)

Editorial: Surgical approaches for the treatment of glioma
gan: G. La Rocca, et al.
Cyhoeddwyd: (2022-11-01)

Validation of multiparametric MRI based prediction model in identification of pseudoprogression in glioblastomas
gan: Laiz Laura de Godoy, et al.
Cyhoeddwyd: (2023-04-01)

Anti-PD-1 Vasculitis of the central nervous system or radionecrosis?
gan: Roger Sun, et al.
Cyhoeddwyd: (2017-12-01)

Histopathologically confirmed radiation-induced damage of the brain – an in-depth analysis of radiation parameters and spatio-temporal occurrence
gan: Mario R. P. Kossmann, et al.
Cyhoeddwyd: (2023-12-01)

Stereotactic radiotherapy for brain metastases: predictive factors of radionecrosis
gan: Benoît Calderon, et al.
Cyhoeddwyd: (2023-07-01)

Next-Generation Sequencing Comparative Analysis of DNA Mutations between Blood-Derived Extracellular Vesicles and Matched Cancer Tissue in Patients with Grade 4 Glioblastoma
gan: Paolo Rosa, et al.
Cyhoeddwyd: (2022-10-01)

Treatment of Laryngeal Radionecrosis with Hyperbaric Oxygen Therapy: A Case Report
gan: Ying-Che Hsu, et al.
Cyhoeddwyd: (2005-02-01)

Pseudoprogression; discussion of the concept of pseudoprogression on the characteristics of tomographic changes in liver metastases of colorectal cancer patients receiving bevacizumab therapy
gan: Pinar Ozdemir Akdur, et al.
Cyhoeddwyd: (2023-09-01)

Pseudoprogression and hyperprogression secondary to immunotherapy in lung cancer
gan: R. Riera-Sala, et al.
Cyhoeddwyd: (2023-09-01)

Radionecrosis cerebral en un adulto
gan: Duniel Abreu Casas, et al.
Cyhoeddwyd: (2024-02-01)

Response assessment of GBM during immunotherapy by delayed contrast treatment response assessment maps
gan: Valeria Cuccarini, et al.
Cyhoeddwyd: (2024-04-01)

MR-Guided Radiotherapy for Brain and Spine Tumors
gan: Danilo Maziero, et al.
Cyhoeddwyd: (2021-03-01)

Impressive reduction of brain metastasis radionecrosis after cabozantinib therapy in metastatic renal carcinoma: A case report and review of the literature
gan: Jacopo Lolli, et al.
Cyhoeddwyd: (2023-03-01)

Corrigendum: Impressive reduction of brain metastasis radionecrosis after cabozantinib therapy in metastatic renal carcinoma: a case report and review of the literature
gan: Jacopo Lolli, et al.
Cyhoeddwyd: (2023-09-01)

A case of pseudoprogression in avelumab maintenance therapy for metastatic bladder cancer
gan: Nozomi Hayakawa, et al.
Cyhoeddwyd: (2023-01-01)

Metabolic pitfall of pseudoprogression after epcoritamab treatment
gan: Osamu Imataki, et al.
Cyhoeddwyd: (2024-12-01)

Time interval from diagnosis to treatment of brain metastases with stereotactic radiosurgery is not associated with radionecrosis or local failure
gan: Justin Leu, et al.
Cyhoeddwyd: (2023-03-01)

Pseudoprogression in advanced non-small cell lung cancer treated with combination chemoimmunotherapy: a case report
gan: Amrit S. Gonugunta, et al.
Cyhoeddwyd: (2022-07-01)

Corrigendum: Time interval from diagnosis to treatment of brain metastases with stereotactic radiosurgery is not associated with radionecrosis or local failure
gan: Justin Leu, et al.
Cyhoeddwyd: (2023-04-01)

Enlarged piloid astrocytoma of the midbrain: recurrence or pseudoprogression? A clinical case
gan: Yu. Yu. Trunin, et al.
Cyhoeddwyd: (2016-03-01)

Pseudoprogression in patients on immunotherapy
gan: D. I. Yudin, et al.
Cyhoeddwyd: (2019-06-01)

Pseudoprogression Disease in a Patient with Small Cell Lung Cancer on Immune Checkpoint Inhibitor Therapy
gan: Zhu W, et al.
Cyhoeddwyd: (2023-09-01)

Analysis of pseudoprogression after proton or photon therapy of 99 patients with low grade and anaplastic glioma
gan: Julianna K. Bronk, et al.
Cyhoeddwyd: (2018-02-01)

Advances in Pseudoprogression of Immune Checkpoint Inhibitors  in Non-small Cell Lung Cancer
gan: Yajun TONG, et al.
Cyhoeddwyd: (2024-04-01)

Pseudoprogression of thoracic tumor after radiotherapy in the era of immunotherapy: a case series
gan: Yongbo Xiang, et al.
Cyhoeddwyd: (2023-07-01)

Dramatic response to pembrolizumab after pseudoprogression in a patient with advanced metastatic castration‐resistant prostate cancer
gan: Takumi Kageyama, et al.
Cyhoeddwyd: (2022-11-01)

Impact of PTV margin reduction (2 mm to 0 mm) on pseudoprogression in stereotactic radiotherapy of solitary brain metastases
gan: Justine Badloe, et al.
Cyhoeddwyd: (2021-03-01)

Effects of Photons Irradiation on 18F-FET and 18F-DOPA Uptake by T98G Glioblastoma Cells
gan: Francesca Pasi, et al.
Cyhoeddwyd: (2020-11-01)

A study method using early dynamic acquisition of [18F]fluorodopa positron emission tomography for the differential diagnosis between progression and radionecrosis of brain metastases after radiotherapy
gan: Ines Barrat, et al.
Cyhoeddwyd: (2024-10-01)

Progress of fMRI on the recurrence and pseudoprogression in glioblastoma
gan: FENG Quan⁃zhi, et al.
Cyhoeddwyd: (2022-04-01)

A Phase 2 Randomised Clinical Trial Assessing the Tolerability of Two Different Ratios of Medicinal Cannabis in Patients With High Grade Gliomas
gan: Janet Schloss, et al.
Cyhoeddwyd: (2021-05-01)